Dose-Ranging Study of Recombinant Human Papillomavirus Virus 16/18 Bivalent Vaccine
Clinical trial NCT01356823 · COMPLETED
Trial details
- NCT number
- NCT01356823
- Sponsor
- Xiamen University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2011-12-01
- Enrollment
- 1600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.